Tumour
New MRI imaging may identify cervical cancer earlyUsing high-resolution magnetic resonance imaging (MRI) with a special vaginal coil, a technique to measure the movement of water within tissue, researchers may be able to identify cervical cancer in its early stages, according to a new study being published in the November issue of Radiology.
Breast stem cell fate is regulated by notchA normal developmental protein that sometimes goes awry has been implicated in breast cancer. This discovery indicates the mechanism by which inappropriate expression of the Notch pathway may contribute to breast cancer.
Moisturisers may increase skin cancer riskMoisturisers used by millions of people may be increasing the risk of common skin cancer like melanoma, hinted by researchers. However, the researchers had cautioned that the experiments were carried out on mice, but the majority of moisturisers have not gone through skin cancer safety checks.
HPV vaccine Cervarix in UK's immunisation programmeThe UK's leading cervical cancer charity, Jo's Trust, has welcomed the UK's Department of Health's announcement that the HPV vaccine, Cervarix will be used in the national immunisation programme for 12/13 year olds starting in September, 2008.
New therapy promising for melanoma skin cancerThe combination of two different biotherapies (interferon alfa-2b and tremelimumab) may be beneficial for patients with inoperable melanoma, revealed by researchers in US.
New melanoma gene close to be identifiedThe researchers are close to discovering a new gene that could help explain variation in melanoma risk. They have identified a region on chromosome 20 (20q11.22) that influences a person's risk of developing melanoma.
International Cancer Genome Consortium sets sights on cancerThe International Cancer Genome Consortium (ICGC), which includes the Wellcome Trust and the Wellcome Trust Sanger Institute in the UK, will generate a valuable resource enabling the development of new and better ways of diagnosing, treating and preventing cancer.
Melanoma skin cancer rising in VictoriaNew figures from The Cancer Council Victoria show that the number of Victorians affected by melanoma is at the highest level ever. Latest figures from the Victorian Cancer Registry show that in 2005, melanoma overtook lung cancer and is now the fourth most common cause of cancer in Victorians.
Zydus Cadila introduces Nudoxa cancer drugZydus Cadila has introduced an NDDS product 'Nudoxa' for the treatment of various cancers. One of the critical drugs used in chemotherapy, Nudoxa heralds a new approach in cancer therapy.
IGFBP7 protein may stop melanoma skin cancerHoward Hughes Medical Institute (HHMI) researchers have uncovered a protein that stops the growth of melanoma, a cancer that develops from pigment-producing cells in the skin called melanocytes.
Changes in X chromosome may lead to mental retardationUniversity of Adelaide geneticist Dr Jozef Gecz and a team of Belgium and UK scientists have achieved a major breakthrough in discovering the causes of intellectual disability. Dr Gecz, a senior researcher who is based at the Women's and Children's Hospital in Adelaide, has collaborated with an international research team to reveal that various mutations of a small part of the X chromosome lead to mental retardation.
Melanomas may appear different than other molesA preliminary study suggests that melanomas have a different appearance than other irregular skin moles (i.e., are "ugly ducklings"), according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
Black women get breast cancer two decades earlier than white womenBlack British women in Hackney, East London, are diagnosed with breast cancer 21 years younger than white British women, according to a Cancer Research UK study published online in the British Journal of Cancer.
PET imaging more accurate in lung cancer stagingPositron emission tomography (PET) is a useful diagnostic tool that supports the need for more accurate staging of lung cancer and improved treatment for patients, concludes an extensive systematic review published online in Journal of National Cancer Institute.